Sterling Pharma Solutions’ Acquisition Of CiVentiChem

Womble Bond Dickinson advised terling Pharma Solutions in its transatlantic acquisition of CiVentiChem.

UK-based Sterling Pharma Solutions has announced its acquisition of CiVentiChem, a contract development and manufacturing organisation located in Cary, NC, near North Carolina’s Research Triangle Park. The acquisition marks Sterling’s first physical location in the US market, and will allow the company to better serve US clients and enhance its chemistry development capabilities to support pre-clinical and early phase clinical supply.

CiVentiChem has been providing simple solutions for complex chemistry problems for over 20 years to pharmaceutical, biotech and other life sciences companies worldwide.

Sterling Pharma Solutions is a eading provider of small molecule API development and manufacturing services to the global pharmaceutical industry.

A transatlantic team led by Melinda Davis Lux (Picture) (US) and Peter Snaith (UK) advised Sterling in this complex cross-border acquisition.

Involved fees earner: Melinda Davis Lux – Womble Bond Dickinson; Peter Snaith – Womble Bond Dickinson;

Law Firms: Womble Bond Dickinson;

Clients: Sterling Pharma Solutions ;

Print Friendly, PDF & Email

Author: Ambrogio Visconti